Your session is about to expire
← Back to Search
Genetic Counseling for Breast Cancer Risk (PCS IV Trial)
N/A
Recruiting
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1- and 6-months post-treatment
Awards & highlights
PCS IV Trial Summary
This trial is testing whether educational and emotional support can help mothers with a risk gene for breast cancer make informed decisions about talking to their children about the disease.
Who is the study for?
This trial is for mothers or primary caregivers to adolescents and young adults aged 13-24 who are undergoing genetic testing for hereditary breast cancer. Participants must be able to speak and read English well.Check my eligibility
What is being tested?
The study aims to find the best ways for BRCA+ mothers to educate their children about hereditary breast cancer risks, manage emotions, and improve psychological well-being through counseling and education.See study design
What are the potential side effects?
Since this trial involves education and counseling rather than medical treatments, there are no direct physical side effects. However, discussing sensitive information may cause emotional or psychological stress.
PCS IV Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1- and 6-months post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1- and 6-months post-treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Communication
PCS IV Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced CareExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Education and counseling
2021
N/A
~270
Find a Location
Who is running the clinical trial?
Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,302 Total Patients Enrolled
33 Trials studying Breast Cancer
12,885 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am the primary caregiver to someone aged 13-24.I am undergoing genetic testing for hereditary breast cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced Care
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the cap for enrolment in this research project?
"Affirmative. Information held on clinicaltrials.gov confirms that this research, originating July 1st 2020, is currently looking for volunteers and has been recently updated October 26th 2020. 200 individuals are required to be recruited from a single site."
Answered by AI
Is it still feasible to join this medical research study?
"This clinical trial is actively recruiting, with the initial posting on July 1st 2020 and its last update taking place on October 26th of the same year."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger